CDC Quietly Revokes COVID Test Emergency Use Authorization, Wait Until You See Why

Something very peculiar and unexpected happened last year during the lockdowns. At least, that’s what is being claimed.

Surprisingly enough, practically nobody contracted the flu last year. The numbers were astronomically low. Isn’t that just amazing? Well…not so fast.

Well, it would be amazing if it were true, but the truth is that this isn’t really the case. I was very suspicious of this reported all last year when I kept seeing the flu at all time lows, yet we saw ȻOVID at the highest levels that we’d seen yet.

If the masks were really supposed to be helping, and the lockdowns were supposed to be helping, and if this is what was preventing the flu from being spread last year, then how on earth would the same measures not be working for ȻOVID as well. It didn’t make sense.

That’s because it was false information. The cases were exaggerated once again, just like they were done in the summer.

According to the CDC,

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.

In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.

This really says it all. The RT-PCR tests could not differentiate between the flu and ȻOVID. So once again, the numbers are proven to be a lie.

You Might Like
Send this to a friend